Table 1 Inhibitions of hMAO-A and hMAO-B by B series.
Compounds | Residual activity at 10 µM (%) | IC50 (µM) | SIa | ||
|---|---|---|---|---|---|
hMAO-A | hMAO-B | hMAO-A | hMAO-B | ||
B1 | 82.62 ± 5.03 | 35.53 ± 6.05 | 26.923 ± 4.160 | 1.441 ± 0.149 | 18.677 |
B2 | 53.15 ± 1.58 | 23.59 ± 0.96 | 13.728 ± 1.531 | 0.626 ± 0.296 | 21.933 |
B3 | 58.32 ± 0.84 | 0 | 14.267 ± 0.203 | 0.261 ± 0.016 | 54.663 |
B4 | 78.25 ± 4.32 | 16.24 ± 6.49 | 29.376 ± 2.708 | 0.233 ± 0.110 | 125.915 |
B5 | 89.21 ± 4.47 | 0 | > 40 | 0.224 ± 0.082 | > 178.651 |
B6 | 92.00 ± 2.93 | 41.33 ± 4.90 | > 40 | 6.550 ± 1.344 | > 6.107 |
B7 | 58.43 ± 4.48 | 0 | 12.597 ± 0.898 | 0.149 ± 0.006 | 84.544 |
B8 | 92.45 ± 0.49 | 64.36 ± 1.50 | > 40 | 17.880 ± 0.268 | > 2.237 |
B9 | 69.09 ± 1.54 | 0 | 23.966 ± 1.443 | 0.236 ± 0.017 | 101.551 |
B10 | 76.67 ± 3.22 | 0 | 33.821 ± 6.888 | 0.067 ± 0.005 | 504.791 |
B11 | 81.27 ± 2.92 | 41.20 ± 0.12 | > 40 | 5.784 ± 2.387 | > 6.915 |
B12 | 86.70 ± 2.68 | 75.44 ± 3.60 | > 40 | 37.559 ± 1.882 | > 1.065 |
B13 | 99.12 ± 1.24 | 1.39 ± 3.27 | > 40 | 0.255 ± 0.016 | > 156.617 |
B14 | 91.23 ± 6.20 | 51.85 ± 1.31 | > 40 | 11.347 ± 0.331 | > 3.525 |
B15 | 75.88 ± 3.10 | 0 | 34.512 ± 3.544 | 0.120 ± 0.010 | 287.600 |
Toloxatone | 1.080 ± 0.025 | – | |||
Lazabemide | – | 0.110 ± 0.016 | |||
Clorgyline | 0.007 ± 0.0007 | – | |||
Pargyline | – | 0.140 ± 0.0059 | |||